What makes Melanotan 2 so special? Melanotan 2 (MT-II) is one of the most studied peptides, so if you’re interested in learning more about it, you should keep reading. There are several hypothesized properties associated with Melanotan 2, an α-MSH analog. This article will discuss research findings in the peptide related to studies in sunless tanning, and sexual dysfunction. Keep reading to discover how researchers suggest this molecule works.
Melanotan 2 Peptide: What is it?
Studies suggest Melanotan 2 (MT-II) may have a lot of promise in various contexts. This manufactured peptide appears to mimic the effects of α-MSH, a melanocortin agonist that serves several physiological purposes. Five distinct receptor types comprise the melanocortin system, which controls the inflammatory response, sexual function, and melanin synthesis.
Research indicates that MT-II may mainly operate on two receptors, MC1R and MC4R, involved in melanogenesis and sexual behavior control. MT-II has a cyclic shortened form. Its action on MC3R receptors is believed to influence metabolism and energy balance.
Because of its increased potency, Melanotan 2, a synthetic analog of α-MSH, is thought to perform comparable tasks more effectively. Animal research has broadened to investigate its other possible impacts despite its origins of development in tanning and pigmentation research.
Related Peptides
Further α-MSH derivatives, including Melanotan 1 (MT-I), are also the subject of extensive research studies. The architecture and functions of MT-I and MT-II are different even though they are both believed to operate on the melanocortin receptors. The structure of MT-II is a ring of amino acids, in contrast to the lengthy and linear MT-1. Both research and clinical contexts also make use of PT-141, a highly modified α-MSH derivative, specifically studied the context of libido (low-sex desire).
Melanotan 2 Peptide: Sunless Tanning
Scientists originally developed this synthetic peptide to induce pigmentation in skin cells and hair follicles. Researchers suggested that concentrations of the “powerful metabotropic peptide,” Melanotan 2, might elicit such an action in the cells. In addition to reducing the requirement for UV exposure to get “tan”, the photoprotective characteristics of higher melanin may lessen the risk of sun damage and some forms of skin cancer.
Melanotan 2 Peptide and Erectile Dysfunction
Since its original development, researchers have expanded the peptide’s area of study, speculating that MT-II, a melanocortin 4 receptor agonist, may potentially influence sexual response as well. The melanocortin 3 receptor may also be involved in this process. Particularly noteworthy is the consideration that peptide exposure may induce erections in animal models of erectile dysfunction (ED). Research suggests that MT-II may potentially strongly affect sexual arousal via the hypothalamus. However, the precise ways this function may work are yet unknown.
Melanotan 2 Peptide: Autism
One animal research study suggested that MT-II might alleviate some of the autistic symptoms, including a lack of social responsiveness, repetitive movements, and trouble communicating. A critical hormone in modulating social attunement, melanocortin 4 is believed to be responsible for this effect via upregulating cerebral Oxytocin. Much research is still ongoing in this area.
Melanotan 2 Peptide: Addictive Behaviours
Animal studies have suggested that MT-II may reduce alcohol intake by activating the melanocortin 4 receptors in the hypothalamus. Among rats with induced alcohol depedency, one study suggested that peptide exposure appeared to have made the rats drink less alcohol and drink more water in comparison to models not exposed to the peptide. According to studies, the melanocortin system appears to be involved in the way the animals react to substances, including amphetamines, cocaine, and opioids. It may also help control impulsive actions, in addition to its potential impacts in addiction. More investigation is now being conducted.
Melanotan 2 Peptide: Food Intake
Animal studies have suggested that MC4R signaling in the hypothalamus may regulate food intake by decreasing hunger and changing macronutrient choices, leading to a decrease in sugar and fat consumption. Especially in MC4R-deficient models of obesity, the exposure to Melanotan 2 in this setting may have consequences for managing the condition.
Melanotan 2 Peptide and Blood Sugar Levels
Data from rodent studies suggests that MT-II may increase insulin sensitivity by influencing blood glucose levels by activating the MC-3 and MC-4 receptors. This may have the potential to alleviate the signs of metabolic diseases.
Melanoatn 2 Peptide and Fat Distribution
In addition to the potential action on hunger and metabolism discussed, MT-II has been hypothesized in animal tests to decrease fat and improve lean muscle mass. By preventing the retention of subcutaneous and visceral adipose tissue and by inducing a caloric deficit, MT-II may lead to decrease obesity. Research studies in animal obesity models drive research into the melanocortin system’s involvement in regulating energy expenditure and fat storage.
There are many other hypothetical avenues that researchers have explored, but this is not a complete list. Emerging research on Melanotan 2 is uncovering new and interesting potential properties in various research scenarios.
Scientists interested in peptides for sale online are encouraged to visit the Core Peptides website for the highest-quality, most affordable research compounds.
References
[i] Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci. 1996;58(20):1777-84. doi: 10.1016/0024-3205(96)00160-9. PMID: 8637402.
[ii] Minakova E, Lang J, Medel-Matus JS, Gould GG, Reynolds A, Shin D, Mazarati A, Sankar R. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autism. PLoS One. 2019 Jan 10;14(1):e0210389. doi: 10.1371/journal.pone.0210389. PMID: 30629642; PMCID: PMC6328175.
[iii] Wessells H, Levine N, Hadley ME, Dorr R, Hruby V. Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II. Int J Impot Res. 2000 Oct;12 Suppl 4:S74-9. doi: 10.1038/sj.ijir.3900582. PMID: 11035391.
[iv] King SH, Mayorov AV, Balse-Srinivasan P, Hruby VJ, Vanderah TW, Wessells H. Melanocortin receptors, melanotropic peptides and penile erection. Curr Top Med Chem. 2007;7(11):1098-1106. PMID: 17584130; PMCID: PMC2694735.
[v] Mahiques-Santos L. Melanotan [Melanotan] Actas Dermosifiliogr. 2021 May;103(4):257-9. Spanish. Doi: 10.1016/j.ad.2011.08.002. PMID: 22051769.
[vi] Hadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006 Apr;27(4):921-30. doi: 10.1016/j.peptides.2005.01.029. Epub. PMID: 16412534.